Filing Details
- Accession Number:
- 0001104659-15-013142
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-23 21:39:59
- Reporting Period:
- 2015-02-19
- Filing Date:
- 2015-02-23
- Accepted Time:
- 2015-02-23 21:39:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1600132 | Bellerophon Therapeutics Inc. | BLPH | Pharmaceutical Preparations (2834) | 473116175 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1280564 | Martin Meglasson | C/O Bellerophon Therapeutics, Inc. 53 Frontage Road, Suite 301 Hampton NJ 08827 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-02-19 | 12,000 | $12.00 | 18,386 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
